Nanoparticle-based insulin delivery: route-specific barriers, innovations, and therapeutic outcomes
{{output}}
Diabetes mellitus (DM) remains a major global health challenge requiring life-long insulin therapy for glycemic control. While subcutaneous (SC) injection is the conventional route of insulin administration, its invasiveness and limited patient adherence under... ...
